pentaerythritol tetranitrate has been researched along with Cardiac Hypertrophy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cebová, M; Koprdová, R; Kristek, F | 1 |
| Baroncini, S; Cornia, GL; Donato, S; Minore, G; Pigini, G; Pretolani, E; Zoli, I | 1 |
2 other study(ies) available for pentaerythritol tetranitrate and Cardiac Hypertrophy
| Article | Year |
|---|---|
Long-term effects of early administered sildenafil and NO donor on the cardiovascular system of SHR.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Cardiovascular System; Carotid Arteries; Coronary Vessels; Disease Models, Animal; Disease Progression; Drug Administration Schedule; Drug Therapy, Combination; Hypertension; Nitric Oxide Donors; Pentaerythritol Tetranitrate; Phosphodiesterase Inhibitors; Piperazines; Purines; Rats; Rats, Inbred SHR; Rats, Wistar; Sildenafil Citrate; Sulfones; Time Factors; Vasodilator Agents | 2007 |
[Therapeutic possibilities in coronary disease].
Topics: Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Arteriosclerosis; Cardiomegaly; Coronary Disease; Drug Combinations; Electrocardiography; Humans; Male; Middle Aged; Myocardial Infarction; Pain; Papaverine; Pentaerythritol Tetranitrate; Pericarditis; Thoracic Diseases; Trifluoperazine; Wolff-Parkinson-White Syndrome | 1973 |